Stem cells are undifferentiated cells with the ability to divide indefinitely and develop into specialized cells throughout the body. These cells have long been a research and therapeutic focus, with laboratories worldwide working to realize the cells’ potential in treating injury and disease. The field of stem cell research is rapidly progressing. But how well
Diabetes can be characterized as either type 1, an autoimmune disease where an individual’s immune cells destroy the beta cells of the pancreas, or type 2, where individuals cannot produce enough insulin and use it properly. People that suffer from diabetes experience high blood glucose that can result in blindness, kidney failure, nerve damage, heart
Researchers at Oregon State University have used X-ray crystallography to take the first atomic-level images of a peroxiredoxin. These images, recently published in the journal Structure, may possibly contribute to a new approach to antibiotics. “Peroxiredoxins are found in animals, plants, and bacteria, and are proteins that are crucial for cell survival,” explained lead author
Stem cells are undifferentiated biological cells that can become specialized cells in various parts of the body and divide to produce more stem cells. The ability of these cells to regenerate tissues and organs of the body have made them a topic of great interest and research. Treatment with stem cells has the promise to treat a wide variety of diseases
A team of researchers has shown how a human protein pathway can control Ebola virus gene expression and replication, findings that provide a new therapeutic target for treating Ebola. The study, recently published in the journal mBio, utilized anti-Zaire Ebola virus antibodies made available on the Kerafast platform by the laboratory of Dr. Christopher F.
Pressure ulcers, or injuries to the skin and underlying tissue due to prolonged pressure on the body, are a common complication in patients confined to a wheelchair or bed for long periods of time, such as those with a spinal cord injury or elderly and infirm populations. In Dr. Amit Gefen’s Musculoskeletal Biomechanics Lab at